Medicus Pharma(MDCX.US)

Last Updated 19:00:00 ET
longbridge loading

Medicus Pharma shares are trading higher after the company announced results from pre-specified expanded Phase 2 SKNJCT-003 data analysis.

benzinga_article·
US
MDCX
-1.38%
benzinga_article·
US
MDCX
-1.38%

EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study

benzinga_article·
US
MDCX
-1.38%
benzinga_article·
US
MDCX
-1.38%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
OGN
-0.30%
US
MDCX
-1.38%
US
SGMT
+5.26%
benzinga_article·
US
OGN
-0.30%
US
MDCX
-1.38%
US
SGMT
+5.26%

Medicus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard

TradingView·
US
MDCX
-1.38%
TradingView·
US
MDCX
-1.38%

Medicus Pharma Upsizes ATM Program to $50 Million With Maxim Group and Yorkville Securities

TradingView·
US
MDCX
-1.38%
TradingView·
US
MDCX
-1.38%

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome | MDCX Stock News

StockTitan·
US
MDCX
-1.38%
StockTitan·
US
MDCX
-1.38%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga_article·
US
ASBP
-7.30%
US
BEAT
+0.31%
US
NDRA
-3.60%
benzinga_article·
US
ASBP
-7.30%
US
BEAT
+0.31%
US
NDRA
-3.60%

EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline

benzinga_article·
US
MDCX
-1.38%
benzinga_article·
US
MDCX
-1.38%
© 2026 Longbridge｜Disclaimer